Week 4 - CVD reading: Flashcards
Results of a prolonged period (≥6 months) of regular intensive exercise in previously untrained individuals
Resting and submaximal exercising heart rates are typically 5–20 beats lower, with an increase in stroke volume of ∼20% and enhanced myocardial contractility.
- Structurally, all four heart chambers increase in volume with mild increases in wall thicknesses, resulting in greater cardiac mass due to increased myocardial cell size.
Exercise and cardiac remodelling:
- The term ‘athlete’s heart’ refers to a constellation of adaptations that affect the structure, electrical conduction and function of the heart that facilitate appropriate increases in cardiac output during exercise. Intensive and prolonged endurance training leads to cardiac remodelling.
- Studies demonstrate dilatation of all four cardiac chambers and an increase in the maximal wall thickness in trained individuals compared with sedentary controls.
Upper limits of cardiac remodelling in athletes:
In absolute terms and regardless of an athlete’s body surface area, the upper limit of physiological hypertrophy in athletes is considered ≥13 mm for maximal wall thickness and ≥65 mm for LV internal diameter in diastole.
Molecular mechanisms of physiological cardiac growth:
- The best characterised signalling cascade responsible for mediating physiological cardiac growth is the insulin-like growth factor-1 (IGF-1)-PI3K(p110α)-Akt pathway.
- Increased cardiac IGF-1 expression and activation of the PI3K (p110α) pathway has been implicated in increased cardiomyocyte hypertrophy with endurance exercise in athletes.
The differences in cellular and structural cardiac adaptations between physiological and pathological remodelling of the heart.
Normal Heart: This represents the baseline heart with normal-sized chambers and regular distribution of cardiomyocytes (muscle cells) and endothelial cardiac stem cells (eCSCs).
Pathological Remodelling:
Seen in conditions such as myocardial infarction (heart attack).
Structural changes: Increase in heart size and myocyte volume, but with thinning of the walls due to cell death and fibrotic replacement.
Cellular changes: Dysfunction of eCSCs leads to impaired regenerative capacity, resulting in cardiac dysfunction.
This remodelling is often considered irreversible and associated with a decline in cardiac function.
Physiological Remodelling:
Observed with endurance exercise training.
Structural changes: Enlarged heart size with proportional wall thickening and increased myocyte volume, ensuring preserved chamber function.
Cellular changes: Activation of eCSCs supports myocyte and vessel renewal, contributing to improved or maintained heart function.
This type of remodelling is typically reversible with cessation of the stressor (e.g., stopping exercise).
Overall, pathological remodelling is maladaptive and impairs cardiac function, whereas physiological remodelling represents a healthy, adaptive response to increased demands.
Flow mediated dilatation (FMD)
The integrity of blood vessels function can be assessed using the technique of flow mediated dilatation (FMD), which uses an ischaemic challenge to induce changes in shear stress that stimulates vasodilation that is NO dependent
- The mechanisms responsible for reduced FDM post exercise relate to an increase in oxidative stress and/or a decline in endothelial (arginine) substrate use to cleave NO
High-intensity exercise may generate oscillatory or retrograde blood flow patterns that hinder nitric oxide (NO) production
Structural changes in the arteries following endurance exercise:
Increased vessel diameter, which normalize shear rates and explain why elite athletes exhibit similar FMD to sedentary individuals despite having larger arteries and thinner walls.
Optimising the CV benefits of exercise
How much exercise?
- While no optimal exercise volume or ‘dose’ has been established, low doses of casual lifelong exercise (2–3 sessions per week) do not prevent the decreased cardiac compliance and distensibility observed in healthy yet sedentary ageing.
- Research observed stiffer ventricles in casual exercisers (2–3 sessions per week) than committed (4–5 exercise sessions per week), with LV distensibility similar between casual exercisers and sedentary individuals.
Optimising the CV benefits of exercise.
How intense should exercise be?
- A meta-analysis of patients with cardiometabolic diseases (ie, coronary artery disease, heart failure, hypertension, metabolic syndrome and obesity) observed significantly greater increases in VO_ 2peak following HIIT compared with Moderate intensity continuous training (MICT), equivalent to 9%, meaning that HIIT improved cardiorespiratory fitness by almost double.
- The vast majority of evidence suggests that regular (≥4 times per week), sustained (≥45 min) and intensive exercise throughout life is the most advantageous to optimise CV health.
Issues with Randomised controlled trials examining the effect of exercise on disease endpoints :
very large sample sizes and long durations of follow-up are needed to detect statistically significant effects on these outcomes (e.g., heart attack and stroke)
Modifiable risk factors for CVD:
- Dyslipidaemia: elevated total cholesterol or low-density lipoprotein cholesterol concentrations, depressed high-density lipotropin cholesterol concentration, elevated triglyceride concentrations
- Hypertension
- Cigarette smoking
- Obesity (particularly central/ abdominal obesity)
- Hyperglycaemia or T2 diabetes
Non-modifiable risk factors for CVD:
- Family history: risk is increased in first-degree relatives of people with premature atherosclerotic disease (<60 years)]]]
- Age: higher risk in older individuals
- Sex: higher risk in men
- Ethnicity: higher risk in individuals with South Asian ethnicity
- Socio-economic status: higher risk with greater deprivation
- Existing diseases/ conditions: higher risk in individuals with T1 diabetes, chronic kidney disease, rheumatoid arthritis, atrial fibrillation or familial hypercholesterolaemia.
Mechanisms through which physical activity can influence cardiovascular disease risk
Increased fitness and decreased body fat can affect several physiological mechanisms:
Insulin sensitivity
Lipid and lipoprotein metabolism
Blood pressure
Vascular function
Inflammation
Lipids, lipoproteins and PA:
Chylomicrons and VLDL are lipoproteins involved in the transport of triglycerides. Chylomicrons carry dietary triglycerides, while VLDL transports triglycerides synthesized in the liver. Both are referred to as triglyceride-rich lipoproteins because they primarily consist of triglycerides. LDL, on the other hand, primarily carries cholesterol in the bloodstream. Elevated levels of chylomicrons, VLDL, and LDL are considered atherogenic, meaning they promote the formation of fatty deposits in the arteries, contributing to cardiovascular disease (CVD).
In contrast, HDL is protective against CVD by facilitating the process of “reverse cholesterol transport,” where excess cholesterol is transferred from tissues to the liver for excretion. Triglyceride-rich lipoproteins are hydrolyzed by lipoprotein lipase (LPL) in capillary beds of adipose tissue and skeletal muscle. This hydrolysis releases non-esterified fatty acids (NEFA) for storage or oxidation and transfers phospholipid surface material and cholesterol to HDL.
High LPL activity can increase HDL levels by promoting the transfer of surface material to HDL. If triglyceride clearance is slow, there is a neutral lipid exchange between triglyceride-rich lipoproteins and HDL, leading to an inverse relationship between plasma triglyceride and HDL concentrations. This process affects the size and composition of both triglyceride-rich lipoproteins and HDL particles.
Considering the role of HDL in reverse cholesterol transport, low HDL concentrations are a risk factor for CVD.
Equally, low HDL concentration may be a marker for defective metabolism of triglyceride-rich lipoprotein.
The combination of low HDL and elevated triglyceride concentrations is also associated with circulating LDL particles that are smaller and more dense than normal.
Atherogenic lipoprotein phenotype’
The combination of low HDL, elevated triglyceride concentrations and smaller denser LDL particles is termed: the ‘atherogenic lipoprotein phenotype’.